Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 5.31 USD -1.48% Market Closed
Market Cap: 161.1m USD
Have any thoughts about
Skye Bioscience Inc?
Write Note

Skye Bioscience Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Skye Bioscience Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Skye Bioscience Inc
NASDAQ:SKYE
PP&E Net
$248.8k
CAGR 3-Years
132%
CAGR 5-Years
N/A
CAGR 10-Years
11%
Abbvie Inc
NYSE:ABBV
PP&E Net
$5.1B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.4B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
14%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6.2B
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$2.5B
CAGR 3-Years
23%
CAGR 5-Years
26%
CAGR 10-Years
13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.4B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
18%

See Also

What is Skye Bioscience Inc's PP&E Net?
PP&E Net
248.8k USD

Based on the financial report for Jun 30, 2024, Skye Bioscience Inc's PP&E Net amounts to 248.8k USD.

What is Skye Bioscience Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
11%

Over the last year, the PP&E Net growth was -25%. The average annual PP&E Net growth rates for Skye Bioscience Inc have been 132% over the past three years , and 11% over the past ten years .

Back to Top